Inventor
Ingrid Maurer-Fogy
Inventor
Vienna, AT
Overview
Patents· 19 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides24%
A61KPreparations for medical, dental or toiletry purposes15%
G01NInvestigating or analysing materials by determining their chemical or physical properties13%
C12NMicroorganisms or enzymes12%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms12%
Y02ATechnologies for adaptation to climate change11%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations7%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests7%
PatentTitleYear
7,282,483'Method of ameliorating the harmful effects of TNF using a polypeptide having the ability to bind to TNF'20077,264,944'TNF receptors, TNF binding proteins and DNAs coding for them'20077,238,776'TNF binding proteins'20076,440,693'TNF receptors, TNF binding proteins and DNAS coding for them'20026,417,158'Method of ameliorating the harmful effects of TNF using a polypeptide having the ability to bind to TNF'20026,294,352'TNF receptors, TNF binding proteins and DNAs coding for them'20016,271,346'TNF Receptors, TNF binding proteins and DNAs coding for them'20016,221,675'TNF receptors, TNF binding proteins and DNAs coding for them'20015,843,791'TNF receptors, TNF binding proteins and DNAs coding for them'19985,837,842'Vascular anticoagulant proteins DNA which codes them, processer for preparing them and their use'19985,710,027'Process and vector for expressing alpha-interferon in E. coli'19985,589,371'Human manganese superoxide dismutase (hMn-SOD)'19965,559,025'Expression of mature proteinase 2A, the partial purification thereof and preparation of substrates having an inhibitory effect'19965,436,162'Human manganese superoxide dismutase (hMn-SOD)'19955,260,204'Human manganese superoxide dismutase (hMn-SOD)'19935,240,847'Human manganese superoxide dismutase (hMn-SOD)'19935,196,323'Process for preparing and purifying alpha-interferon'19935,149,783'Expression of the virally coded protease P2A of HRV2'19924,917,887'Hybrid interferons, their use as pharmaceutical compositions and as intermediate products for the preparation of antibodies and the use thereof and processes for preparing them'1990Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1990–1998Patents assigned to BOEHRINGER INGELHEIM INT (10)· patent assignee history
1990–2007Based in Vienna, AT· patent location history
1996Based in Wien, AT· patent location history
1998Based in Lindauergasse, AT· patent location history
2001–2007Patents assigned to AMGEN INC (7)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BOEHRINGER INGELHEIM INT | 10 | 1990–1998 |
| AMGEN INC | 7 | 2001–2007 |
Locations
| Location | Patents | Span |
|---|---|---|
| Vienna, AT | 17 | 1990–2007 |
| Lindauergasse, AT | 1 | 1998 |
| Wien, AT | 1 | 1996 |